Cargando…

Drug-drug interactions in patients with COVID-19

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677439/ http://dx.doi.org/10.1007/s40278-020-86264-6

Ejemplares similares

Drug interaction between hydroxychloroquine and metformin
Publicado: (2020)

Pfizer COVID-19-related drug use and safety surveillance
Publicado: (2021)

Evaluation of the Potential for Drug Interactions With Patiromer in Healthy Volunteers
por: Lesko, Lawrence J., et al.
Publicado: (2017)

Sex differences in ADR reports for drugs used to treat COVID-19
Publicado: (2020)

Pazopanib exposure decreases as a result of an ifosfamide-dependent drug–drug interaction: results of a phase I study
por: Hamberg, P, et al.
Publicado: (2014)

An update on drug-drug interactions for care of the acutely ill in the era of COVID-19
por: Patanwala, Asad E, et al.
Publicado: (2023)

Specialty and cancer drugs set to drive US drug expenditure in 2021
Publicado: (2021)

Adverse Reactions to Antituberculosis Drugs in Iranian Tuberculosis Patients
por: Farazi, Aliasghar, et al.
Publicado: (2014)

Drug Resistance among Pulmonary Tuberculosis Patients in Calabar, Nigeria
por: Otu, Akaninyene, et al.
Publicado: (2013)

Postoperative seizures in meningioma patients: improving patient selection for antiepileptic drug therapy
por: Islim, Abdurrahman I., et al.
Publicado: (2018)

Detecting Drug-Drug Interactions in COVID-19 Patients
por: Jeong, Eugene, et al.
Publicado: (2022)

The effectiveness of antiepileptic drug treatment in glioma patients: lamotrigine versus lacosamide
por: van Opijnen, Mark P., et al.
Publicado: (2021)

Combining phenome-driven drug-target interaction prediction with patients’ electronic health records-based clinical corroboration toward drug discovery
por: Zhou, Mengshi, et al.
Publicado: (2020)

The cost-effectiveness of screening lung cancer patients for targeted drug sensitivity markers
por: Atherly, A J, et al.
Publicado: (2012)

A Study on Drug-Drug Interaction of Esomeprazole and Anti-Diabetic Drugs
por: Swamy, VKM, et al.
Publicado: (2010)

Hydroxychloroquine concentrations persist after drug discontinuation
Publicado: (2022)

Does the cancer drugs fund lead to faster uptake of cost-effective drugs? A time-trend analysis comparing England and Wales
por: Chamberlain, C, et al.
Publicado: (2014)

Economic Burden of Drug Use in Patients with Acute Burns: Experience in a Developing Country
por: Ogundipe, Kolawole Olubunmi, et al.
Publicado: (2009)

Effect of antiepileptic drugs in glioma patients on self-reported depression, anxiety, and cognitive complaints
por: van der Meer, Pim B., et al.
Publicado: (2021)

Drug–Drug Interactions in Patients with COVID-19 in Nursing Homes
por: Correard, Florian, et al.
Publicado: (2021)

Telemedicine improves drug adherence and reduces OOP costs
Publicado: (2021)

Pioglitazone Attenuates Drug-Eluting Stent-Induced Proinflammatory State in Patients by Blocking Ubiquitination of PPAR
por: Wang, Zhongxia, et al.
Publicado: (2016)

Real-World Experience with Dolutegravir-Based Two-Drug Regimens
por: Ward, Douglas, et al.
Publicado: (2020)

Frequency of Adverse Events of Antithyroid Drugs Administered during Pregnancy
por: Yoshihara, Ai, et al.
Publicado: (2014)

Choice of Antiepileptic Drugs in Idiopathic Generalized Epilepsy: UAE Experience
por: Alsaadi, Taoufik, et al.
Publicado: (2015)

Changes of Nitric Oxide and Peroxynitrite Serum Levels during Drug Therapy in Patients with Obsessive-Compulsive Disorder
por: Kouti, Leila, et al.
Publicado: (2016)

Effects of Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Response to Periodontal Treatment in Patients with Rheumatoid Arthritis
por: Jung, Gyu-Un, et al.
Publicado: (2018)

COVID‐19 treatment in patients with comorbidities: Awareness of drug‐drug interactions
por: Back, David, et al.
Publicado: (2020)

Drug-Drug Interactions among Patients Hospitalized with COVID-19 in Greece
por: Spanakis, Marios, et al.
Publicado: (2022)

Hyponatremic Cognitive Dysfunction Resulting from Drug-Drug-Gene Interaction between Sertraline and Cannabidiol in an Intermediate CYP2C19 Metabolizer Patient
por: Nanan, Jade Camara, et al.
Publicado: (2022)

Prevalence of Anemia and Risk of Adverse Bleeding Effect of Drugs: Implication for Therapy
por: Uba Nwose, Ezekiel
Publicado: (2012)

Repurposing Drugs in Oncology (ReDO)—mebendazole as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2014)

Repurposing Drugs in Oncology (ReDO)—itraconazole as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2015)

Repurposing Drugs in Oncology (ReDO)—diclofenac as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2016)

Repurposing drugs in oncology (ReDO)—cimetidine as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2014)

Repurposing Drugs in Oncology (ReDO)—nitroglycerin as an anti-cancer agent
por: Sukhatme, Vidula, et al.
Publicado: (2015)

Repurposing Drugs in Oncology (ReDO)—Propranolol as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2016)

Potential Drug–Drug Interactions with Antimicrobials in Hospitalized Patients: A Multicenter Point-Prevalence Study
por: Kuscu, Ferit, et al.
Publicado: (2018)

Disease-drug and drug-drug interaction in COVID-19: Risk and assessment
por: Kumar, Devendra, et al.
Publicado: (2021)

mRNA COVID-19 vaccines safe in patients with previous COVID-19 infections
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mdgckusdhbcec251l9h789b8fp